Top Medical News

NeurologyLive® Friday 5 — November 26, 2021

November 26, 2021

By NeurologyLive® Staff

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 26, 2021.

Exercise Training and Multiple Sclerosis

November 26, 2021

By Robert W. Motl, PhD

In line with the push for more comprehensive care, literature suggests that patients with multiple sclerosis benefit from physical therapy interventions to help manage disease symptoms.

Tolebrutinib Adds to the Growing Momentum of BTK Inhibitors in MS

November 26, 2021

By Marco Meglio

The Bruton tyrosine kinase inhibitor has been evaluated in 2 phase 3 trials, GEMINI 1 and GEMINI 2 (NCT04410978; NCT04410991), in patients with relapsing-remitting and relapsing secondary progressive MS.

The Comprehensive Management of Dravet Syndrome

November 25, 2021

By Marco Meglio

In a NeurologyLive® Insights series, experts in the diagnosis and treatment of Dravet syndrome discussed the management of the disease and the utilization of approved treatments to improve outcomes in patients.

Advanced Practice Providers’ Perspectives on Optimal Multiple Sclerosis Management

November 25, 2021

By Matt Hoffman

In a NeurologyLive® Peer Exchange series, experts on the care of patients with multiple sclerosis offer recommendations for selecting and sequencing therapies used to treat patients with relapsing disease.

Featured

Episode 51: The State of Sleep Medicine

Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Karl Doghramji, MD, FAASM, DFAPA.

NeuroVoices: Orrin Devinsky, MD, Heart Rate Variability as a SUDEP Biomarker

The director of the Comprehensive Epilepsy Center at NYU Langone discussed his recently published research, which identified a novel biomarker for sudden unexpected death in epilepsy.

Disease Spotlight: NMOSD

Explore NeurologyLive's coverage of the news and updates on the clinical care of patients with neuromyelitis optica spectrum disorder, including interviews with experts in the field and the latest FDA actions.

Disease Spotlight: Multiple Sclerosis

Explore NeurologyLive's coverage of the news and updates on the clinical care of patients with multiple sclerosis, including interviews with experts in the field and the latest FDA actions.

Latest Videos

Cannabidiol’s Approval on Dravet and Lennox-Gastaut Syndromes

Early Initiation of Therapy for RRMS

Reversing Neurodegeneration in Multiple Sclerosis

ATH-1017 Phase 2 Completes Enrollment, Heart Rate Variability as SUDEP Biomarker, Migraine Not Associated With Insomnia

Future Research Regarding Anticoagulant Use in Reducing Recurrent Stroke: Alexander Merkler, MD, MS

Forward Thinking to Improve SUDEP Prevention, Awareness: Orrin Devinsky, MD

Choosing Treatments for Patients With Multiple Sclerosis: Devon Conway, MD

Treating Insomnia With Related Comorbid Conditions: Michael Thorpy, MD

New Medications for Multiple Sclerosis Treatment: Devon Conway, MD

Role Heart Rate Variability Plays in SUDEP Research, Prevention: Orrin Devinsky, MD

Realistic Outlook for Mesenchymal Stem Cells, Other Treatments in Progressive MS: Jeffrey Cohen, MD

Next Steps, Future Development of FUS Technology in Alzheimer Disease: Ali Rezai, MD

AMX0035 Shows Safety in Alzheimer Disease, Outcomes of Urgent Prevention in TIA, FDA Grants IDE to NeuroPace's RNS System

Most Recent

Addressing Unmet Needs in Narcolepsy Management: Practical Insight for Community-Based Physicians

November 26, 2021

Video

Closing out his discussion on narcolepsy management, Chris Winter, MD, highlights current unmet needs and shares practical advice for community physicians.

Practical Advice for Managing Morning OFF Episodes in Parkinson Disease

November 26, 2021

Video

Closing out his review of on-demand therapies for morning OFF episodes in Parkinson disease, Peter A. LeWitt, MD, shares practical advice for community neurologists.

Parkinson Disease: SL Apomorphine Hydrochloride for Morning OFF Episodes

November 26, 2021

Video

Peter A. LeWitt, MD, discusses the use of sublingual apomorphine hydrochloride compared with its subcutaneous formulation in Parkinson disease.

Factors in Selecting Optimal Therapy for Patients With Narcolepsy

November 26, 2021

Video

Comprehensive insight on the factors that should inform which therapeutic approach, including novel agents such as solriamfetol, should be used to manage narcolepsy.

Moving Toward a More Personalized MS Treatment Journey

November 25, 2021

Article

The field of MS is shifting focus to issues such as understanding and tracking disease progression, approaches to treatment initiation, and the roles of diet and exercise in pathogenesis and disease course.

The Cost of Alzheimer Disease: Aducanumab’s Price and the Implications for CMS, Patients

November 24, 2021

Article

Aducanumab’s (Aduhelm; Biogen) $56,000 price point reflects the larger challenges of the United States’ insurance system and incites a cyclical series of events that have repercussions on cost of future therapies, state budgets, and legislative decisions.

Karl Doghramji, MD, on the Advances in Sleep Disorder Care in 2021

November 24, 2021

Article

The medical director of the Jefferson Sleep Disorders Center at the Vickie and Jack Farber Institute for Neuroscience of Jefferson Health offered his insight into the current state of care for sleep and the progress made this year.

Patient Enrollment Open for CHALLENGE-MIG Study in Migraine

November 24, 2021

Article

The study is the first and only to compare the 2 anticalcitonin gene-related peptide medicines for migraine preventive treatment.

NeuroVoices: Orrin Devinsky, MD, on Unanswered Questions With SUDEP, Heart Rate Variability

November 24, 2021

Article

The director of the Comprehensive Epilepsy Center at NYU Langone discussed the large-scale impact heart rate variability has on preventing SUDEP and the unanswered questions that remain.

AAN Issues Statement on Ethical Considerations for Aducanumab Use in Alzheimer Disease

November 23, 2021

Article

The American Academy of Neurology’s statement touched on the roles played by the principles of beneficence, nonmaleficence, justice, and patient autonomy as it relates to the clinical use of the therapy for this patient population.